Consensus Guidelines for Influenza Vaccination in Patients with Diabetes

Sukamto Koesnoe, Anshari Saifuddin Hasibuan, Ketut Suastika, Cissy Kartasasmita, Andi Makbul Aman, Ida Ayu Kshanti, Wismandari Wisnu, Samsuridjal Djauzi, Iris Rengganis, Alvina Widhani, Suzy Maria, Erwanto Budi Winulyo, Hindra Irawan, Heri Nugroho, Nanny Soetedjo, Sobagijo Adi, Hendra Zufry, Nabilla Gita

Abstract


Influenza is a prevalent health issue encountered in daily practice. Patients with diabetes mellitus face a higher risk of infections, including influenza, owing to the compromised immune system associated with diabetes. This susceptibility arises from the potential of diabetes mellitus to weaken the immune system. Moreover, elevated blood glucose levels can create a conducive environment for the growth of bacteria and viruses. This consensus is formulated by a multidisciplinary team to serve as practical guidance for the administration of influenza vaccinations to patients with diabetes mellitus in daily practice.


Keywords


influenza; diabetes mellitus; vaccination

References


Agustian D, Mutyara K, Murad C, et al. The Epidemiology and population-based incidence of influenza in two communities, Bandung District, West Java, Indonesia, 2008-2011. Research Square. 2019.doi.org/10.21203/rs.2.13626/v1

Lafond KE, Praptiningsih CY, Mangiri A, et al. Seasonal influenza and Avian influenza A(H5N1) virus surveillance among inpatients and outpatients, East Jakarta, Indonesia, 2011-2014. Emerg Infect Dis. 2019;25(11):2031-9.

Kosen S, Indriasih E, Rosita T, et al. Influenza disease burden and cost estimates in Indonesia. Researchgate (poster). 2019.

Kementrian Kesehatan RI, Badan Penelitian dan Pengembangan Kesehatan, Laporan Nasional Riset Kesehatan Dasar 2018.

International Diabetes Federation. IDF Diabetes Atlas, 10th Edition, Brussels, 2021.

Wensveen TT, Gasparani D, Rahelic D, Wensveen FM. Type 2 diabetes and viral infection; cause and effect of disease. Diabetes Research and Clinical Practice. 2021;172:108637.

CDC. Key facts about Influenza (Flu) [Internet]. October 2022 [cited July 2023] Available from: https://www.cdc.gov/flu/about/keyfacts.htm

Allard R, Leclerc P, Tremblay C, Tannenbaum TN. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care. 2010;33:1491–3.

Valdez R, Narayan KM, Geiss LS, Engelgau MM. Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults. Am J Public Health. 1999; 89(11):1715-21.

Lewing BD, Wallick C, To TM, Masters H, et al. Short and long-term impact of influenza infection on individuals with type 2 diabetes: Effect on healthcare utilization and diabetes complications. Diabetes Manag. 2021;11(2):171-9.

International Diabetes Federation (IDF) Europe Position Paper on Vaccination of People Living with Diabetes, 2021.

Djauzi S, Rengganis I, Sundoro J, et al. Pedoman imunisasi pada orang dewasa 2022. Jakarta: Interna Publishing; 2023.

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices – United States, 2022-2023 Influenza Season. MMWR Recomm Rep. 2022;71(No. RR-1):1–28.

Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012; 8(1):81–8.

CDC. What you need to know about diabetes and adult vaccinations [Internet]. October 2022 [cited July 2023]. Available from: https://www.cdc.gov/vaccines/hcp/adults/downloads/fs-diabetes-vaccines.pdf

Santos GD, Tarat H, Berkani RB. Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: A systematic review. Hum Vaccin Immunother. 2018; 14(8):1853-66.

Remschmidt C, Wichmann O, Harder T. Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. BMC Med. 2015;13:53.

Goeijenbier M, Sloten TT, Slobbe L, et al. Benefits of flu vaccination for persons with diabetes mellitus: a review.Vaccine. 2017;35(38):5905-101.

Yedlapati SH, Khan SU, Talluri S, et al. Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: A systematic review and meta-analysis. J Am Heart Assoc. 2021;10(6):e019636.

Wang IK, Li Lin C, Lin PC, et al. Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. PLoS One. 2013;8(3):e58317.

Akin L, Macabeo B, Caliskan Z, Altinel S, Satman I. Cost-effectiveness of increasing influenza vaccination coverage in adults with type 2 diabetes in Turkey. PLoS One. 2016;11(6):e0157657.

Blonde L, Umpierrez GE, Reddy SS, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022. Endocr Pract. 2022; 28(10):923-1049.

American Diabetes Association. Standards of medical care in diabetes - 2023. Diabetes Care Volume 46. 2023.

Chen Z, Bancej C, Lee L, Champion D. Antigenic drift and epidemiological severity of seasonal influenza in Canada. Sci Rep. 2022;12:15625.

Ferdinans, et al. Clinical Infectious Diseases. 2021;73(4):726–72.

Tam YH, Valkenburg SA, Perera RAP, et al. Immune responses to twice-annual influenza vaccination in older adults in Hong Kong. Clin Infect Dis. 2018;66(6):904-12.

CDC. Influenza Prevention: Information for Travelers | CDC [Internet]. October 2021 [cited July 2023]. Available from: https://www.cdc.gov/flu/school business/travelersfacts.htm

Fröbert O, Gotberg M, Angeras O, et al. Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial. Am Heart J. 2017;189:94-102.

Kuster SP, Shah PS, Coleman BL, et al. Incidence of influenza in healthy adults and healthcare workers: a systematic review and meta-analysis. PloS One. 2011; 6(0): e26239.

CDC. Flu information for people with diabetes and caregivers of people with diabetes [Internet]. Jan 2010 [cited July 2023]. Available from: https://www.cdc.gov/h1n1flu/diabetes/diabetes_factsheet.ht

Hulsizer AL, Witte Ap, Attridge RL, Urteaga EM, et al. Hyperglycemia post-influenza vaccine in patients with diabetes. Ann Pharmacother. 2023;57(1):51-4.

CDC. Who should and who should not get a flu vaccine? [Internet]. Sep 2022 [cited July 2023]. Available from: https://www.cdc.gov/flu/professionals/vaccination/vax-summary.html

CDC. Flu vaccine and people with egg allergies. [Internet]. Sep 2022 [cited July 2023]. Available from: https://www.cdc.gov/flu/professionals/vaccination/vax-summary.html

Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 2008;26 (Suppl 4):D49–53.

CDC. Types of influenza viruses [Internet]. March 2023 [cited July 2023]. Available from: https://www.cdc.gov/flu/about/viruses/types.htm

Nair H, Abdullah Brooks W, Katz M, et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis. Lancet 2011;378:1917–3.

World Health Organization. Influenza (Seasonal) [Internet]. January 2023 [cited July 2023]. Available from: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)

Kosasih H, Roselinda, Nurhayati, et al. Surveillance of Influenza in Indonesia, 2003-2007. Influenza Other Respi Viruses. 2013;7(3):312–20.

Restrepo BI, Camerlin AJ, Rahbar MH, et al. Cross-sectional assessment reveals high diabetes prevalence among newly diagnosed tuberculosis cases. Bull World Health Organ. 2011;89(5):352-9.

Thomas S, Ouhtit A, Khatib HA, et al. Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients. Journal of Infection and Public Health. 2022;15(4):412-24.

Stranga ME, Van der Crabben SN, Blumer RME, et al. Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia. Blood. 2009;112(1): 82-89.

Nenna R, Papoff P, Moretti C, et al. Detection of respiratory viruses in the 2009 winter season in Rome: 2009 Influenza A (H1N1) complications in children and concomitant type 1 diabetes onset. International Journal of Immunopathology and Pharmacology. 2011;24(3):651-9.

Vamos EP, Pape UJ, Cucin V, et al. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. CMAJ. 2016; 188(4):e342-e351.

Wang IK, Lin CL, Chang YC, et al. Effectiveness of influenza vaccination in elderly diabetic patients: A retrospective cohort study. Vaccine. 2013;31(4):718-24.


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.